All News
F.D.A. Scientists Are Reinstated at Agency Food Safety Labs
After 20 percent of the agency’s work force was cut, federal health officials have decided to bring back some experts and review firings to fill gaps in critical roles.
Read MoreTrump Budget Draft Ends Narcan Program and Other Addiction Measures
A $56 million grant to train emergency responders and supply them with the overdose reversal spray, plus other programs that address addiction, could be eliminated.
Read MoreACA's Preventive Services Mandate: What's at Stake?
(MedPage Today) -- Since its enactment in 2010, the Affordable Care Act (ACA) has afforded millions of people access to comprehensive and affordable health insurance -- improving their health and f
Read MoreTrump Budget Draft Ends Narcan Program and Other Addiction Measures
A $56 million grant to train emergency responders and supply them with the overdose reversal spray, plus other programs that address addiction, could be eliminated.
Read MoreSTAT+: Up and down the ladder: The latest comings and goings
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
Read MoreSTAT+: Akeso wins Chinese approval for cancer drug positioned to rival Merck’s Keytruda
An Akeso lung cancer drug that beat Merck’s Keytruda in a head-to-head trial won approval in China this week
Read MoreRFK Jr. Recounts Heroin Addiction, Urges Focus on Prevention and Community
(MedPage Today) -- HHS Secretary Robert F. Kennedy Jr.
Read MoreSTAT+: Vanderbilt medical center warns suppliers not to raise prices due to tariffs, or they may not get paid
Amid growing anxiety over tariffs, one medical center has warned its suppliers that any sudden price hikes attributed to the levies may be rejected.
Read MoreDelgocitinib Cream More Effective Than Oral Alitretinoin for Severe Hand Eczema
(MedPage Today) -- Delgocitinib cream had superior efficacy and a better safety profile compared with oral alitretinoin for the treatment of severe chronic hand eczema, the randomized phase III DELTA
Read MoreMounting Evidence for Psoriasis Cure
(MedPage Today) -- Recent advances in molecular and pathobiology have brought the field of dermatology to the cusp of reaching a goal that seemed highly improbable or impossible just a few years ago:
Read More